Drug Shortage Report for GLN-URSODIOL
Report ID | 242232 |
Drug Identification Number | 02426900 |
Brand name | GLN-URSODIOL |
Common or Proper name | GLN-Ursodiol |
Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | URSODIOL |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100 tablets |
ATC code | A05AA |
ATC description | BILE THERAPY |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-11-01 |
Actual start date | 2024-11-02 |
Estimated end date | 2024-12-18 |
Actual end date | 2024-12-20 |
Shortage status | Resolved |
Updated date | 2024-12-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-12-23 | French | Compare |
v9 | 2024-12-23 | English | Compare |
v8 | 2024-12-16 | French | Compare |
v7 | 2024-12-16 | English | Compare |
v6 | 2024-12-05 | French | Compare |
v5 | 2024-12-05 | English | Compare |
v4 | 2024-11-18 | French | Compare |
v3 | 2024-11-18 | English | Compare |
v2 | 2024-11-07 | French | Compare |
v1 | 2024-11-07 | English | Compare |
Showing 1 to 10 of 10